539 related articles for article (PubMed ID: 19514974)
1. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers.
Al-Kassas RS; El-Khatib MM
Drug Deliv; 2009 Apr; 16(3):145-52. PubMed ID: 19514974
[TBL] [Abstract][Full Text] [Related]
2. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin.
Liu Z; Li J; Nie S; Liu H; Ding P; Pan W
Int J Pharm; 2006 Jun; 315(1-2):12-7. PubMed ID: 16616442
[TBL] [Abstract][Full Text] [Related]
3. In situ ophthalmic gel of ciprofloxacin hydrochloride for once a day sustained delivery.
Jain SP; Shah SP; Rajadhyaksha NS; Singh P S PP; Amin PD
Drug Dev Ind Pharm; 2008 Apr; 34(4):445-52. PubMed ID: 18401787
[TBL] [Abstract][Full Text] [Related]
4. Thermosensitive and pH induced in situ ophthalmic gelling system for ciprofloxacin hydrochloride: hydroxypropyl-beta-cyclodextrin complex.
Başaran B; Bozkir A
Acta Pol Pharm; 2012; 69(6):1137-47. PubMed ID: 23285675
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization.
Khan N; Aqil M; Imam SS; Ali A
Pharm Dev Technol; 2015; 20(6):662-9. PubMed ID: 24754411
[TBL] [Abstract][Full Text] [Related]
6. Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients.
Shimoyama T; Itoh K; Kobayashi M; Miyazaki S; D'Emanuele A; Attwood D
Drug Dev Ind Pharm; 2012 Aug; 38(8):952-60. PubMed ID: 22283456
[TBL] [Abstract][Full Text] [Related]
7. Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride.
Balasubramaniam J; Pandit JK
Drug Deliv; 2003; 10(3):185-91. PubMed ID: 12944139
[TBL] [Abstract][Full Text] [Related]
8. Effect of hydroxypropyl-beta-cyclodextrin on the solubility, stability and in-vitro release of ciprofloxacin for ocular drug delivery.
Bozkir A; Denli ZF; Basaran B
Acta Pol Pharm; 2012; 69(4):719-24. PubMed ID: 22876616
[TBL] [Abstract][Full Text] [Related]
9. Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels.
Mansour M; Mansour S; Mortada ND; Abd Elhady SS
Drug Dev Ind Pharm; 2008 Jul; 34(7):744-52. PubMed ID: 18612913
[TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin liposomes as vesicular reservoirs for ocular delivery: formulation, optimization, and in vitro characterization.
Mehanna MM; Elmaradny HA; Samaha MW
Drug Dev Ind Pharm; 2009 May; 35(5):583-93. PubMed ID: 19031311
[TBL] [Abstract][Full Text] [Related]
11. Prolonged delivery of ciprofloxacin hydrochloride from hydrophilic ocular inserts.
Samanta A; Ghosal SK
Acta Pol Pharm; 2004; 61(5):343-9. PubMed ID: 15747690
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of gel-forming ocular films based on xyloglucan.
Mahajan HS; Deshmukh SR
Carbohydr Polym; 2015 May; 122():243-7. PubMed ID: 25817665
[TBL] [Abstract][Full Text] [Related]
13. In situ gelling of alginate/pluronic solutions for ophthalmic delivery of pilocarpine.
Lin HR; Sung KC; Vong WJ
Biomacromolecules; 2004; 5(6):2358-65. PubMed ID: 15530052
[TBL] [Abstract][Full Text] [Related]
14. Sustained ophthalmic delivery of ofloxacin from an ion-activated in situ gelling system.
Abraham S; Furtado S; Bharath S; Basavaraj BV; Deveswaran R; Madhavan V
Pak J Pharm Sci; 2009 Apr; 22(2):175-9. PubMed ID: 19339228
[TBL] [Abstract][Full Text] [Related]
15. Effect of salts on gelation and drug release profiles of methylcellulose-based ophthalmic thermo-reversible in situ gels.
Bhowmik M; Bain MK; Ghosh LK; Chattopadhyay D
Pharm Dev Technol; 2011 Aug; 16(4):385-91. PubMed ID: 20429816
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of polymeric films for buccal drug delivery.
Skulason S; Asgeirsdottir MS; Magnusson JP; Kristmundsdottir T
Pharmazie; 2009 Mar; 64(3):197-201. PubMed ID: 19348343
[TBL] [Abstract][Full Text] [Related]
17. [In situ gelling polymers for ophthalmic drops].
Sklubalová Z
Ceska Slov Farm; 2005 Jan; 54(1):4-10. PubMed ID: 15751788
[TBL] [Abstract][Full Text] [Related]
18. In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations.
Almeida H; Amaral MH; Lobão P; Lobo JM
Drug Discov Today; 2014 Apr; 19(4):400-12. PubMed ID: 24120893
[TBL] [Abstract][Full Text] [Related]
19. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
[TBL] [Abstract][Full Text] [Related]
20. Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment.
Mehanna MM; Elmaradny HA; Samaha MW
Drug Dev Ind Pharm; 2010 Jan; 36(1):108-18. PubMed ID: 19656004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
